As of 2025-08-06, the EV/EBITDA ratio of Korea Bio-Gen Co Ltd (318000.KQ) is 10.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 318000.KQ's latest enterprise value is 41,783.73 mil KRW. 318000.KQ's TTM EBITDA according to its financial statements is 4,027.41 mil KRW. Dividing these 2 quantities gives us the above 318000.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 3.2x - 11.3x | 6.9x |
| Forward P/E multiples | 3.6x - 5.6x | 4.6x |
| Fair Price | 1,993.82 - 5,717.10 | 3,869.54 |
| Upside | -62.4% - 7.9% | -27.0% |
| Date | EV/EBITDA |
| 2025-08-04 | 10.59 |
| 2025-08-01 | 10.74 |
| 2025-07-31 | 10.48 |
| 2025-07-30 | 10.05 |
| 2025-07-29 | 10.35 |
| 2025-07-28 | 9.85 |
| 2025-07-25 | 9.72 |
| 2025-07-24 | 9.94 |
| 2025-07-23 | 9.24 |
| 2025-07-22 | 9.41 |
| 2025-07-21 | 9.71 |
| 2025-07-18 | 8.86 |
| 2025-07-17 | 8.66 |
| 2025-07-16 | 8.67 |
| 2025-07-15 | 8.68 |
| 2025-07-14 | 8.73 |
| 2025-07-11 | 8.73 |
| 2025-07-10 | 8.73 |
| 2025-07-09 | 8.70 |
| 2025-07-08 | 8.74 |
| 2025-07-07 | 8.74 |
| 2025-07-04 | 8.75 |
| 2025-07-03 | 8.79 |
| 2025-07-02 | 8.66 |
| 2025-07-01 | 8.60 |
| 2025-06-30 | 8.49 |
| 2025-06-27 | 8.53 |
| 2025-06-26 | 8.74 |
| 2025-06-25 | 8.82 |
| 2025-06-24 | 8.84 |
| 2025-06-23 | 8.84 |
| 2025-06-20 | 8.82 |
| 2025-06-19 | 8.69 |
| 2025-06-18 | 8.66 |
| 2025-06-17 | 8.63 |
| 2025-06-16 | 8.74 |
| 2025-06-13 | 8.79 |
| 2025-06-12 | 8.88 |
| 2025-06-11 | 8.99 |
| 2025-06-10 | 8.75 |
| 2025-06-09 | 8.78 |
| 2025-06-05 | 8.71 |
| 2025-06-04 | 8.76 |
| 2025-06-02 | 8.61 |
| 2025-05-30 | 8.49 |
| 2025-05-29 | 8.37 |
| 2025-05-28 | 8.44 |
| 2025-05-27 | 8.20 |
| 2025-05-26 | 8.53 |
| 2025-05-23 | 8.60 |